The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue

International Journal of Obesity

Volumn 36, Issue 10, 2012, Pages 1360-1365

  Kovacova, Z ^a   Tencerova, M ^a   Roussel, B ^b,c   Wedellova, Z ^a   Rossmeislova, L ^a   Langin, D ^b,c   Polak, J ^a   Stich, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSERM   (France)

^c Departments of Clinical Biochemistry and Sports Medicine   (France)

Author keywords

Adiponectin; Adipose tissue; Body fat distribution

Indexed keywords

ADIPONECTIN; ISOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; SUBCUTANEOUS FAT;

ADIPONECTIN; ADULT; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PROTEIN ISOFORMS; SUBCUTANEOUS FAT;

EID: 84873723494     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.223     Document Type: Article

References (46)

1. Despres JP, Lemieux I, Prud’homme D. Treatment of obesity: Need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716-720.
2. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
3. Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 2008; 51: 155-164.
4. Liu A, McLaughlin T, Liu T, Sherman A, Yee G, Abbasi F, Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes Surg 2009; 19: 1564-1573.
5. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 2009; 11: 11-18.
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
8. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
9. Montague CT, O’Rahilly S. The perils of portliness: Causes and consequences of visceral adiposity. Diabetes 2000; 49: 883-888.
10. Bajzova M, Kovacikova M, Vitkova M, Klimcakova E, Polak J, Kovacova Z, Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity. Physiol Res 2008; 57: 927-934.
11. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002; 87: 5662-5667.
12. Drolet R, Belanger C, Fortier M, Huot C, Mailloux J, Legare D, Fat depotspecific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 2009; 17: 424-430.
13. Hernandez-Morante JJ, Milagro FI, Lujan JA, Martinez JA, Zamora S, Garaulet M. Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients. Clin Endocrinol (Oxf) 2008; 69: 412-417.
14. Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab 2009; 297: E767-E773.
15. Wang Y, Lam KS, Yau MH, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008; 409: 623-633.
16. Bouskila M, Pajvani UB, Scherer PE. Adiponectin: A relevant player in PPARgammaagonist-mediated improvements in hepatic insulin sensitivity? Int J Obes (Lond) 2005; 29 (1): S17-S23.
17. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363.
18. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162.
19. Fisher FF, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE, Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005; 48: 1084-1087.
20. Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007; 56: 1493-1499.
21. Hajri T, Tao H, Wattacheril J, Marks-Shulman P, Abumrad NN. Regulation of adiponectin production by insulin: Interactions with tumor necrosis factor-alpha and interleukin-6. Am J Physiol Endocrinol Metab 2011; 300: E350-E360.
22. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008; 38: 827-834.
23. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
24. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53: 1966-1971.
25. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 1391-1396.
26. Kovacova Z, Vitkova M, Kovacikova M, Klimcakova E, Bajzova M, Hnevkovska Z, Secretion of adiponectin multimeric complexes from adipose tissue explants is not modified by very low calorie diet. Eur J Endocrinol 2009; 160: 585-592.
27. Polak J, Kovacova Z, Jacek M, Klimcakova E, Kovacikova M, Vitkova M, An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women. Clin Sci (Lond) 2007; 112: 557-565.
28. Murdolo G, Hammarstedt A, Schmelz M, Jansson PA, Smith U. Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individuals. J Clin Endocrinol Metab 2009; 94: 4508-4516.
29. Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR. Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab 2008; 295: E842-E850.
30. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005; 54: 2712-2719.
31. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a largescale middle-aged to elderly population: The Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2008; 93: 715-722.
32. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb 2010; 17: 1201-1211.
33. Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006; 291: E1100-E1105.
34. Kusminski CM, McTernan PG, Schraw T, Kos K, O’Hare JP, Ahima R, Adiponectin complexes in human cerebrospinal fluid: Distinct complex distribution from serum. Diabetologia 2007; 50: 634-642.
35. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Structurefunction studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073-9085.
36. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008; 149: 2270-2282.
37. Halberg N, Schraw TD, Wang ZV, Kim JY, Yi J, Hamilton MP, Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009; 58: 1961-1970.
38. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 2007; 30: 210-214.
39. Bambace C, Telesca M, Zoico E, Sepe A, Olioso D, Rossi A, Adiponectin gene expression and adipocyte diameter: A comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011; 20: E153-e156.
40. Pasarica M, Tchoukalova YD, Heilbronn LK, Fang X, Albu JB, Kelley DE, Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) 2009; 17: 1976-1978.
41. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
42. Cao YL, Hu CZ, Meng X, Wang DF, Zhang J. Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity. Diabetes Res Clin Pract 2008; 79: 214-219.
43. Zha JM, Di WJ, Zhu T, Xie Y, Yu J, Liu J, Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults. Endocr J 2009; 56: 935-944.
44. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099.
45. Lo J, Bernstein LE, Canavan B, Torriani M, Jackson MB, Ahima RS, Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab 2007; 293: E102-E109.
46. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab 2011; 96: E146-E150.